Solesence, Inc. Common Stock (SLSN) 10-Year Financial Performance & Capital Metrics

SLSN • • Industrial / General

Consumer DefensiveHousehold ProductsPersonal Care & CosmeticsSkincare & Hair Care

AboutSolésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The company partners with global and indie brands, leveraging its proprietary Active Stress Defense™ technology suite to bring environmental protection beauty products to market.Show more

Revenue $52M +40.4%
EBITDA $6M +316.1%
Net Income $4M +196.5%
EPS (Diluted) 0.07 +179.0%
Gross Margin 30.92% +47.4%
EBITDA Margin 11.58% +254.0%
Operating Margin 9.8% +203.1%
Net Margin 8.09% +168.7%
ROE 50.27% +143.2%
ROIC 15.31% +223.8%
Debt/Equity 1.02 -90.8%
Interest Coverage 7.66 +281.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Efficient asset utilization: 1.0x turnover

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 6 (bottom 6%)
✗Low quality earnings: Net income not backed by cash flow
✗Shares diluted 31.2% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y21.1%

TTM30.04%

Profit (Net Income) CAGR

10Y-

5Y-

3Y22.21%

TTM-59.9%

EPS CAGR

10Y-

5Y-

3Y11.87%

TTM-44.7%

ROCE

10Y Avg1.66%

5Y Avg1.66%

3Y Avg-1.84%

Latest24.72%

Peer Comparison

Skincare & Hair Care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AXILAXIL Brands, Inc.	52.99M	7.79	77.90	-4.51%	3.26%	8.85%	2.9%	0.08
ULUnilever PLC	141.09B	64.70	28.25	1.94%	10.16%	61.19%	5.51%	1.36
CLColgate-Palmolive Company	66.87B	82.96	23.64	3.31%	14.47%	234.81%	5.3%	15.65
PGThe Procter & Gamble Company	337.05B	144.24	22.16	0.29%	19.74%	31.31%	4.17%	0.68
SLSNSolesence, Inc. Common Stock	107.22M	1.52	21.71	40.35%	1.72%	6.21%		1.02
EPCEdgewell Personal Care Company	861.43M	18.44	9.36	0.09%	2.94%	4.13%	20.26%	0.87
UGUnited-Guardian, Inc.	28.76M	6.26	8.82	11.91%	19.48%	18.52%	10.55%

Profit & Loss

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	29.48M	37.32M	37.3M	52.35M
Revenue Growth %	-	0.27%	-0%	0.4%
Cost of Goods Sold+	20.79M	28.96M	29.47M	36.16M
COGS % of Revenue	0.71%	0.78%	0.79%	0.69%
Gross Profit+	8.69M	8.36M	7.83M	16.19M
Gross Margin %	0.29%	0.22%	0.21%	0.31%
Gross Profit Growth %	-	-0.04%	-0.06%	1.07%
Operating Expenses+	6.13M	10.62M	11.37M	11.06M
OpEx % of Revenue	0.21%	0.28%	0.3%	0.21%
Selling, General & Admin	3.9M	7.58M	7.53M	7.22M
SG&A % of Revenue	0.13%	0.2%	0.2%	0.14%
Research & Development	2.23M	3.04M	3.84M	3.84M
R&D % of Revenue	0.08%	0.08%	0.1%	0.07%
Other Operating Expenses	0	0	0	0
Operating Income+	2.56M	-2.26M	-3.55M	5.13M
Operating Margin %	0.09%	-0.06%	-0.1%	0.1%
Operating Income Growth %	-	-1.88%	-0.57%	2.45%
EBITDA+	3.01M	-1.69M	-2.8M	6.06M
EBITDA Margin %	0.1%	-0.05%	-0.08%	0.12%
EBITDA Growth %	-	-1.56%	-0.66%	3.16%
D&A (Non-Cash Add-back)	454K	567K	742K	928K
EBIT	3.51M	-2.26M	-3.55M	5.13M
Net Interest Income+	-1.15M	-382K	-838K	-670K
Interest Income	0	0	0	0
Interest Expense	1.15M	382K	838K	670K
Other Income/Expense	-202K	-382K	-838K	-670K
Pretax Income+	2.36M	-2.64M	-4.38M	4.46M
Pretax Margin %	0.08%	-0.07%	-0.12%	0.09%
Income Tax+	37K	-17K	6K	227K
Effective Tax Rate %	0.98%	0.99%	1%	0.95%
Net Income+	2.32M	-2.62M	-4.39M	4.24M
Net Margin %	0.08%	-0.07%	-0.12%	0.08%
Net Income Growth %	-	-2.13%	-0.67%	1.96%
Net Income (Continuing)	2.32M	-2.62M	-4.39M	4.24M
Discontinued Operations	0	0	0	0
Minority Interest	0	0	0	0
EPS (Diluted)+	0.05	-0.05	-0.09	0.07
EPS Growth %	-	-2.07%	-0.66%	1.79%
EPS (Basic)	0.05	-0.05	-0.09	0.07
Diluted Shares Outstanding	47.04M	49.12M	49.56M	65.03M
Basic Shares Outstanding	45.02M	49.12M	49.56M	62.35M
Dividend Payout Ratio	-	-	-	-

Balance Sheet

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	11.6M	16.63M	16.3M	29.35M
Cash & Short-Term Investments	657K	2.19M	1.72M	1.41M
Cash Only	657K	2.19M	1.72M	1.41M
Short-Term Investments	0	0	0	0
Accounts Receivable	3.94M	4.73M	3.47M	4.87M
Days Sales Outstanding	48.75	46.3	33.93	33.95
Inventory	6.09M	8.84M	10.03M	20.27M
Days Inventory Outstanding	107.03	111.41	124.23	204.58
Other Current Assets	0	866K	1.08M	2.8M
Total Non-Current Assets+	16.8M	16.93M	16.58M	20.65M
Property, Plant & Equipment	16.79M	16.93M	16.57M	20.65M
Fixed Asset Turnover	1.76x	2.20x	2.25x	2.53x
Goodwill	0	0	0	0
Intangible Assets	0	0	0	0
Long-Term Investments	0	0	0	0
Other Non-Current Assets	8K	6K	4K	3K
Total Assets+	28.39M	33.56M	32.88M	50M
Asset Turnover	1.04x	1.11x	1.13x	1.05x
Asset Growth %	-	0.18%	-0.02%	0.52%
Total Current Liabilities+	7.34M	13.84M	15.59M	25.77M
Accounts Payable	3.89M	6.77M	6.39M	10.69M
Days Payables Outstanding	68.24	85.28	79.11	107.91
Short-Term Debt	1.35M	4.28M	4.81M	5M
Deferred Revenue (Current)	905K	1000K	1000K	1000K
Other Current Liabilities	0	0	0	0
Current Ratio	1.58x	1.20x	1.05x	1.14x
Quick Ratio	0.75x	0.56x	0.40x	0.35x
Cash Conversion Cycle	87.55	72.43	79.05	130.62
Total Non-Current Liabilities+	13.59M	14.07M	15.39M	9.28M
Long-Term Debt	1M	4M	6M	0
Capital Lease Obligations	11.71M	9.82M	9.15M	9.04M
Deferred Tax Liabilities	0	0	0	0
Other Non-Current Liabilities	222K	230K	238K	246K
Total Liabilities	20.93M	27.91M	30.98M	35.06M
Total Debt+	14.75M	18.11M	21.26M	15.3M
Net Debt	14.09M	15.92M	19.54M	13.89M
Debt / Equity	1.98x	3.20x	11.18x	1.02x
Debt / EBITDA	4.90x	-	-	2.52x
Net Debt / EBITDA	4.68x	-	-	2.29x
Interest Coverage	2.22x	-5.91x	-4.23x	7.66x
Total Equity+	7.46M	5.65M	1.9M	14.95M
Equity Growth %	-	-0.24%	-0.66%	6.86%
Book Value per Share	0.16	0.12	0.04	0.23
Total Shareholders' Equity	7.46M	5.65M	1.9M	14.95M
Common Stock	489K	493K	496K	700K
Retained Earnings	-97.45M	-100.07M	-104.66M	-100.43M
Treasury Stock	0	0	0	0
Accumulated OCI	0	0	0	0
Minority Interest	0	0	0	0

Cash Flow

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	2.32M	-1.65M	-2.01M	1.97M
Operating CF Margin %	0.08%	-0.04%	-0.05%	0.04%
Operating CF Growth %	-	-1.71%	-0.22%	1.98%
Net Income	2.32M	-2.62M	-4.39M	4.24M
Depreciation & Amortization	454K	567K	742K	928K
Stock-Based Compensation	160K	625K	773K	725K
Deferred Taxes	0	0	0	0
Other Non-Cash Items	-49K	2.57M	0	0
Working Capital Changes	-564K	-2.79M	869K	-3.92M
Change in Receivables	-1M	-797K	1.06M	-1.4M
Change in Inventory	-1.75M	-2.74M	-1.19M	-10.24M
Change in Payables	1.03M	0	-503K	2.4M
Cash from Investing+	-1.87M	-2.82M	-1.05M	-4.56M
Capital Expenditures	-1.87M	-2.82M	-1.05M	-4.56M
CapEx % of Revenue	0.06%	0.08%	0.03%	0.09%
Acquisitions	-	-	-	-
Investments	-	-	-	-
Other Investing	0	0	0	0
Cash from Financing+	-747K	6M	2.59M	2.27M
Debt Issued (Net)	-	-	-	-
Equity Issued (Net)	-	-	-	-
Dividends Paid	0	0	0	0
Share Repurchases	-	-	-	-
Other Financing	234K	6.11M	73K	2.08M
Net Change in Cash	-	-	-	-
Free Cash Flow+	447K	-4.47M	-3.06M	-2.59M
FCF Margin %	0.02%	-0.12%	-0.08%	-0.05%
FCF Growth %	-	-11.01%	0.32%	0.15%
FCF per Share	0.01	-0.09	-0.06	-0.04
FCF Conversion (FCF/Net Income)	1.00x	0.63x	0.46x	0.47x
Interest Paid	218K	333K	752K	637K
Taxes Paid	0	0	0	0

Key Ratios

Metric	2021	2022	2023	2024
Return on Equity (ROE)	31.08%	-40%	-116.28%	50.27%
Return on Invested Capital (ROIC)	8.9%	-7.85%	-12.37%	15.31%
Gross Margin	29.48%	22.4%	20.98%	30.92%
Net Margin	7.87%	-7.03%	-11.77%	8.09%
Debt / Equity	1.98x	3.20x	11.18x	1.02x
Interest Coverage	2.22x	-5.91x	-4.23x	7.66x
FCF Conversion	1.00x	0.63x	0.46x	0.47x
Revenue Growth	-	26.61%	-0.05%	40.35%

Revenue by Segment

	2021	2022	2023	2024
Consumer Products	-	-	-	44.37M
Consumer Products Growth	-	-	-	-
Personal Care ingredients	-	11.12M	9.28M	6.83M
Personal Care ingredients Growth	-	-	-16.58%	-26.41%
Advanced Materials	7.74M	3.08M	2.81M	1.15M
Advanced Materials Growth	-	-60.14%	-8.95%	-59.17%
Solesence	3.56M	23.11M	25.21M	-
Solesence Growth	-	549.00%	9.09%	-
Personal Care Ingredients	18.18M	-	-	-
Personal Care Ingredients Growth	-	-	-	-

Revenue by Geography

	2021	2022	2023	2024
Non-US	3.24M	1.97M	2.92M	1.82M
Non-US Growth	-	-39.09%	48.05%	-37.46%

Frequently Asked Questions

Valuation & Price

Solesence, Inc. Common Stock (SLSN) has a price-to-earnings (P/E) ratio of 21.7x. This is roughly in line with market averages.

Growth & Financials

Solesence, Inc. Common Stock (SLSN) reported $62.1M in revenue for fiscal year 2024. This represents a 111% increase from $29.5M in 2021.

Solesence, Inc. Common Stock (SLSN) grew revenue by 40.4% over the past year. This is strong growth.

Yes, Solesence, Inc. Common Stock (SLSN) is profitable, generating $1.1M in net income for fiscal year 2024 (8.1% net margin).

Dividend & Returns

Solesence, Inc. Common Stock (SLSN) has a return on equity (ROE) of 50.3%. This is excellent, indicating efficient use of shareholder capital.

Solesence, Inc. Common Stock (SLSN) had negative free cash flow of $11.2M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener